|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 9/00 | |||
| A61K 31/00 | |||
| A61K 38/02 | |||
| C07K 16/40 |
| (11) | Patento numeris | 2386316 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10183216.0 |
| Europos patento paraiškos padavimo data | 2005-06-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-11-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 578847 P | 2004-06-10 | US |
| (72) |
Schwaeble, Hans-Wilhelm, GB
Stover, Cordula M., GB
Tedford, Clark E., US
Parent, James B., US
Fujita, Teizo, JP
|
| (73) |
UNIVERSITY OF LEICESTER,
University Road, Leicester, Leicestershire LE1 7RH,
GB
Omeros Corporation, 201 Elliott Avenue West, Seattle, WA 98119, US |
| (54) | Methods for treating conditions associated with MASP-2 dependent complement activation |
| Methods for treating conditions associated with MASP-2 dependent complement activation |